Literature DB >> 15948754

Superselective embolization of bladder arteries in the treatment of intractable bladder haemorrhage.

Ettore De Berardinis1, Patrizio Vicini, Filippo Salvatori, Alessandoro Sciarra, Vincenzo Gentile, Franco Di Silverio.   

Abstract

Bladder hemorrhage following radiation therapy is a serious complication in patients undergoing this treatment. Several methods have been proposed to control this particular situation; however, results have been far from satisfactory, with the exception of drastic measures such as hypogastric artery ligation and radical cystectomy. We recently used a method of superselective embolization of the bladder arteries which enabled us to control severe intractable bleeding in a patient submitted to bladder irradiation for a transitional cell infiltrating carcinoma. Compared to selective embolization and other methods, the advantages of superselective embolization are a lower recurrence rate concerning bleeding, fewer side-effects and the possibility of using adaptable embospheres (150-1000 micron) which, on account of their marked plasticity, offer better occlusion of the vessels. For these reasons, superselective embolization of the bladder arteries should be considered as the treatment of choice in intractable bladder hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948754     DOI: 10.1111/j.1442-2042.2005.01074.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  11 in total

1.  Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis.

Authors:  Suyash Mohan; Sunil Kumar; Deepak Dubey; Rajendra V Phadke; Sanjay S Baijal; Manoj Kathuria
Journal:  World J Urol       Date:  2018-12-17       Impact factor: 4.226

2.  Selective embolization of the internal iliac arteries for the treatment of intractable hemorrhage in children with malignancies.

Authors:  Sul Hee Bae; Dong Kyun Han; Hee Jo Baek; Sun Ju Park; Nam Kyu Chang; Hoon Kook; Tai Ju Hwang
Journal:  Korean J Pediatr       Date:  2011-04-30

3.  Superselective internal iliac arterial embolization for severe hemorrhage following radical prostatectomy.

Authors:  Sheng Cheng; Liwei Xu; Gonghui Li; Yuebing Chen; Hongjie Hu; Zhigen Zhang; Guoqing Ding
Journal:  Oncol Lett       Date:  2012-06-11       Impact factor: 2.967

Review 4.  Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies.

Authors:  Bernadette M M Zwaans; Laura E Lamb; Sarah Bartolone; Heinz E Nicolai; Michael B Chancellor; Stangel-Wójcikiewicz Klaudia
Journal:  Int Urol Nephrol       Date:  2018-08-21       Impact factor: 2.370

5.  Challenges and Opportunities in Radiation-induced Hemorrhagic Cystitis.

Authors:  Bernadette M M Zwaans; Heinz G Nicolai; Michael B Chancellor; Laura E Lamb
Journal:  Rev Urol       Date:  2016

Review 6.  Management of radiation cystitis.

Authors:  Shaun G Smit; Chris F Heyns
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

7.  Superselective embolisation of bilateral superior vesical arteries for management of intractable hematuria in context of metastatic bladder cancer.

Authors:  Ahmed Saadi; Abderrazak Bouzouita; Mohamed Hedi Rebai; Mohamed Cherif; Walid Kerkeni; Haroun Ayed; Amine Derouiche; Hatem Rajhi; Riadh Ben Slama; Najla Mnif; Mohamed Chebil
Journal:  Asian J Urol       Date:  2016-05-01

8.  Endovascular Management of Radiation-Induced Hemorrhagic Cystitis.

Authors:  Ganesh G Gowda; R Vijayakumar; Maureen P Tigga
Journal:  Indian J Palliat Care       Date:  2019 Jul-Sep

Review 9.  Selective embolisation for intractable bladder haemorrhages: A systematic review of the literature.

Authors:  Diaa-Eldin Taha; Ahmed A Shokeir; Omar A Aboumarzouk
Journal:  Arab J Urol       Date:  2018-03-02

Review 10.  Urological complications after radiation therapy-nothing ventured, nothing gained: a Narrative Review.

Authors:  Joanna Chorbińska; Wojciech Krajewski; Romuald Zdrojowy
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.